Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10p -2.35% 4.15p 4.00p 4.30p 4.25p 4.15p 4.25p 602,972 12:30:42
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.4 -0.3 -0.3 - 2.98

Physiomics Share Discussion Threads

Showing 26701 to 26723 of 26725 messages
Chat Pages: 1069  1068  1067  1066  1065  1064  1063  1062  1061  1060  1059  1058  Older
DateSubjectAuthorDiscuss
18/12/2018
14:43
Pyc is the most b.s ramped share on here, lse, twitter and probably myspace no doubt
davevt
18/12/2018
14:27
Lot of ramping going on in here is this another pump and dump job by you lot
grahamwales
18/12/2018
09:36
Anyone notice how Stig has abandoned here, still plugging on twitter though.
davevt
18/12/2018
08:48
But stig compared off to others with 100m plus market cap surely that's enough for us to be up there with them????
spacedust
18/12/2018
08:23
yes there is no i.p, their patents expired years ago, in fact they are using is rather antiquated compared to their peers.
davevt
18/12/2018
08:22
Bill, of course it isn't news. If the 2017 rns was '1 year contract' and then this year they have renewed, then that is kind of news....but last time I checked, this is a company, with customers...and most customer are repeat customers. Do you think Ford release an rns every year when a long term customer buys another fleet of vans? (Which ironically fleet van contracts are much more money than what Merck is spending) No, because this is normal course of business stuff. But this isn't even that, because the original rns told you it was a 'multi year agreement', so completely expected, and already priced in. Don't argue with me, argue with the share price, because it's indicating exactly that.
davevt
18/12/2018
07:42
bobdown2 - "I.p is where the value is at." That is where the value is at with all these tiddler biotech companies that multi-bag or are bought out for multiples of their market cap. A little research on your part will show you that this company has no I.P. If it has I challenge you to post any of it here and I will gladly withdraw my comment. The word 'intellectual property' has long since been dropped and replaced with 'industry standard technologies'.
pwhite73
17/12/2018
18:25
Bought few today. Pyc could turn very interesting next year and although there is no real income I.p is where the value is at. It has taken years to harvest and direct this information and the rns states that more benefits will emerge next year. Ps. Straight away I notice a filter...checked out the six posts today and my sentiment...if you want to get nasty with a share do not do it to one involved in trying to help with oncology. .
bobdown2
17/12/2018
17:58
It is news. What a stupid thing to say. We will just announce the details of this year's Merck agreement.No don't be silly no one will want to know that partic those doomsayers out there that reckon it might gave been nowt this year.Whats that you say it's 500k euros well that's lower than last year so will they not bang on about how it is lower as the exchange rate isn't so good.Yeah if course they will but it wouldn't matter what we said they will still beat their big drum. After all this isn't even a contract its only a multi year agreement!!!! Lets just keep each years details to ourselves in future!!!
billthebank
17/12/2018
17:22
There is no reason to, pyc told you it was a multi year agreement over a year ago. This isn't 'news'.
davevt
17/12/2018
16:14
Well,it seems that nobody is impressed with this latest rns today. The price does not seem to be moving.
cinquepercento
17/12/2018
15:44
It's funny watching the new yet behind the rampers presto, funkybeat and riddler getting it completely wrong on LSE and twitter..
davevt
17/12/2018
15:40
I'm in with 100k. I got a a newly feeling Jim the cunning might buy some and then sell them on for few multiples. Jc come out come out wherever you are and make some money here
spacedust
17/12/2018
12:27
I think you find that they do have something on the way. Placings that is which generated lots of working capital for Jim the cunning
spacedust
17/12/2018
11:27
What do they have underway? Tell us.
davevt
17/12/2018
11:22
This company will be making money soon,they have something underway. DYOR.
myamay16
17/12/2018
10:32
New customers spending money = miracle
spacedust
17/12/2018
09:25
You need new customers spending lots of money, which as I said before can't happen as they all need to start at the bottom on 35k contracts. As pwhite says, this company isn't designed to 'make money'.
davevt
17/12/2018
09:10
We need either JC or a miracle to get this going again
spacedust
17/12/2018
09:03
Who said zero Rev? I specifically wrote 'Merck will be spending less, or even nothing this year, and maybe even next year, hence why pyc inserted the caveat of 'the value of the services after the next year is not guaranteed'' Oh and how about this.. 'anyway, even if they were spending 500k again, that's already priced in. It would have to be much more, or a new customer to shift the price.' It's like I can foresee the future.
davevt
17/12/2018
09:00
Davevt what about the BS people posting zero rev.? Like for a year....
officerdigby
17/12/2018
08:27
Exactly, it's like people thought Merck spending the money each year would put the share price up. They are an old customer, you need new contracts. I said if they spent again it would be lower, and hence why pyc said 'future revenues are not guaranteed', and the b.s people were saying of 'minimum of 500k'. Nope.
davevt
17/12/2018
08:15
Almost 500k but share price will remain in the doldrums. Very frustrating. Last year it bagged 32 times. This year id be happy with 3 baggers
spacedust
Chat Pages: 1069  1068  1067  1066  1065  1064  1063  1062  1061  1060  1059  1058  Older
Your Recent History
LSE
PYC
Physiomics
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181219 03:03:27